BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18286258)

  • 1. Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans.
    Stefan N; Peter A; Cegan A; Staiger H; Machann J; Schick F; Claussen CD; Fritsche A; Häring HU; Schleicher E
    Diabetologia; 2008 Apr; 51(4):648-56. PubMed ID: 18286258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.
    Lee JJ; Lambert JE; Hovhannisyan Y; Ramos-Roman MA; Trombold JR; Wagner DA; Parks EJ
    Am J Clin Nutr; 2015 Jan; 101(1):34-43. PubMed ID: 25527748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios.
    Peter A; Cegan A; Wagner S; Lehmann R; Stefan N; Königsrainer A; Königsrainer I; Häring HU; Schleicher E
    Clin Chem; 2009 Dec; 55(12):2113-20. PubMed ID: 19850634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.
    Gutiérrez-Juárez R; Pocai A; Mulas C; Ono H; Bhanot S; Monia BP; Rossetti L
    J Clin Invest; 2006 Jun; 116(6):1686-95. PubMed ID: 16741579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the role of stearoyl-CoA desaturase-1 in hepatic insulin resistance.
    Flowers MT; Miyazaki M; Liu X; Ntambi JM
    J Clin Invest; 2006 Jun; 116(6):1478-81. PubMed ID: 16741573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
    Dobrzyn A; Ntambi JM
    Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet.
    Silbernagel G; Kovarova M; Cegan A; Machann J; Schick F; Lehmann R; Häring HU; Stefan N; Schleicher E; Fritsche A; Peter A
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2288-92. PubMed ID: 23015656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic knockdown of stearoyl-CoA desaturase 1 via RNA interference in obese mice decreases lipid content and changes fatty acid composition.
    Xu H; Wilcox D; Nguyen P; Voorbach M; Smith H; Brodjian S; Suhar T; Reilly RM; Jacobson PB; Collins CA; Landschulz K; Surowy TK
    Front Biosci; 2007 May; 12():3781-94. PubMed ID: 17485339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro.
    Pinnamaneni SK; Southgate RJ; Febbraio MA; Watt MJ
    Diabetologia; 2006 Dec; 49(12):3027-37. PubMed ID: 17033839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans.
    Peter A; Cegan A; Wagner S; Elcnerova M; Königsrainer A; Königsrainer I; Häring HU; Schleicher ED; Stefan N
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E321-6. PubMed ID: 21045174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet.
    Kuda O; Stankova B; Tvrzicka E; Hensler M; Jelenik T; Rossmeisl M; Flachs P; Kopecky J
    J Physiol Pharmacol; 2009 Dec; 60(4):135-40. PubMed ID: 20065507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice.
    Miyazaki M; Sampath H; Liu X; Flowers MT; Chu K; Dobrzyn A; Ntambi JM
    Biochem Biophys Res Commun; 2009 Mar; 380(4):818-22. PubMed ID: 19338759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zingiber officinale extract administration diminishes steroyl-CoA desaturase gene expression and activity in hyperlipidemic hamster liver by reducing the oxidative and endoplasmic reticulum stress.
    Carnuta MG; Deleanu M; Barbalata T; Toma L; Raileanu M; Sima AV; Stancu CS
    Phytomedicine; 2018 Sep; 48():62-69. PubMed ID: 30195881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterculic oil, a natural inhibitor of SCD1, improves the metabolic state of obese OLETF rats.
    Ortinau LC; Nickelson KJ; Stromsdorfer KL; Naik CY; Pickering RT; Haynes RA; Fritsche KL; Perfield JW
    Obesity (Silver Spring); 2013 Feb; 21(2):344-52. PubMed ID: 23404766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis.
    Miyazaki M; Flowers MT; Sampath H; Chu K; Otzelberger C; Liu X; Ntambi JM
    Cell Metab; 2007 Dec; 6(6):484-96. PubMed ID: 18054317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty Acid Metabolism and Associations with Insulin Sensitivity Differs Between Black and White South African Women.
    Goedecke JH; Chorell E; van Jaarsveld PJ; Risérus U; Olsson T
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e140-e151. PubMed ID: 32995848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo.
    Peter A; Weigert C; Staiger H; Machicao F; Schick F; Machann J; Stefan N; Thamer C; Häring HU; Schleicher E
    Diabetes; 2009 Aug; 58(8):1757-65. PubMed ID: 19478146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver.
    Kotronen A; Seppänen-Laakso T; Westerbacka J; Kiviluoto T; Arola J; Ruskeepää AL; Oresic M; Yki-Järvinen H
    Diabetes; 2009 Jan; 58(1):203-8. PubMed ID: 18952834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hepatic desaturases in obesity-related metabolic disorders.
    Bjermo H; Risérus U
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):703-8. PubMed ID: 20823776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.